31 related articles for article (PubMed ID: 1971430)
1. Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task.
Pezze MA; Dalley JW; Robbins TW
Neuropsychopharmacology; 2007 Feb; 32(2):273-83. PubMed ID: 16641946
[TBL] [Abstract][Full Text] [Related]
2. Central dopamine D
Ikeda H; Yonemochi N; Mikami R; Abe M; Kawamura M; Natsume R; Sakimura K; Waddington JL; Kamei J
Sci Rep; 2020 Dec; 10(1):22347. PubMed ID: 33339892
[TBL] [Abstract][Full Text] [Related]
3. Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutryic acid from rat striatal slices.
Arias-Montaño JA; Floran B; Garcia M; Aceves J; Young JM
Br J Pharmacol; 2001 May; 133(1):165-71. PubMed ID: 11325806
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.
Burgess CR; Tse G; Gillis L; Peever JH
Sleep; 2010 Oct; 33(10):1295-304. PubMed ID: 21061851
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.
Nielsen J; Fejgin K; Sotty F; Nielsen V; Mørk A; Christoffersen CT; Yavich L; Lauridsen JB; Clausen D; Larsen PH; Egebjerg J; Werge TM; Kallunki P; Christensen KV; Didriksen M
Transl Psychiatry; 2017 Nov; 7(11):1261. PubMed ID: 29187755
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-Dopa, SKF-38393, and quinpirole on exploratory, anxiety- and depressive-like behaviors in pubertal female and male mice.
Moraes MA; Árabe LB; Resende BL; Codo BC; Reis ALAL; Souza BR
Behav Brain Res; 2024 Feb; 459():114805. PubMed ID: 38096922
[TBL] [Abstract][Full Text] [Related]
7. The role of the nucleus accumbens in learned approach behavior diminishes with training.
Dobrovitsky V; West MO; Horvitz JC
Eur J Neurosci; 2019 Nov; 50(9):3403-3415. PubMed ID: 31340074
[TBL] [Abstract][Full Text] [Related]
8. Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine.
Stopper CM; Khayambashi S; Floresco SB
Neuropsychopharmacology; 2013 Apr; 38(5):715-28. PubMed ID: 23303055
[TBL] [Abstract][Full Text] [Related]
9. Sex similarities and dopaminergic differences in interval timing.
Stutt HR; Weber MA; Cole RC; Bova AS; Ding X; McMurrin MS; Narayanan NS
bioRxiv; 2023 May; ():. PubMed ID: 37205472
[TBL] [Abstract][Full Text] [Related]
10. In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.
Ng SS; Pang CC
Br J Pharmacol; 2000 Mar; 129(5):853-8. PubMed ID: 10696081
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.
Eilam D; Talangbayan H; Canaran G; Szechtman H
Psychopharmacology (Berl); 1992; 106(4):447-54. PubMed ID: 1533720
[TBL] [Abstract][Full Text] [Related]
12. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
Wedzony K; Limberger N; Späth L; Wichmann T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):250-5. PubMed ID: 3264055
[TBL] [Abstract][Full Text] [Related]
14. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.
Schorderet M; Nowak JZ
Cell Mol Neurobiol; 1990 Sep; 10(3):303-25. PubMed ID: 2174740
[TBL] [Abstract][Full Text] [Related]
15. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions.
Jin GZ; Zhu ZT; Fu Y
Trends Pharmacol Sci; 2002 Jan; 23(1):4-7. PubMed ID: 11804640
[No Abstract] [Full Text] [Related]
16. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
Barnes JM; Barnes NM; Costall B; Naylor RJ
Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
[TBL] [Abstract][Full Text] [Related]
17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
